NCT06961604View on ClinicalTrials.gov

A Novel Method for Determination of Thromboembolic Stroke Origin

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2025

Study Completion Date

May 31, 2026

Conditions

Thromboembolic Stroke

Interventions

DRUG

NaF PET-CT

Following a non-cardiogenic thromboembolic stroke, patients will undergo NaF PET-CT imaging to identify the culprit plaque and any other vulnerable plaques at high risk for rupture

Trial Locations (1)

07901

Overlook Medical Center, Summit